Atossa Therapeutics (ATOS) Q3 2024 Earnings Report
MX:ATOS Q3 2024 EPS Results
- Actual EPS
- -MXN 16.91
- Consensus EPS
- -MXN 16.91
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -MXN 14.09
MX:ATOS Q3 2024 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- MXN 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/12/2024
- Time
- Before Open
- Conference Call
- Tuesday, November 12, 2024
MX:ATOS Upcoming Earnings
Atossa Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ATOS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -16.10- | -19.73 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | -19.26-17.85 | -19.73 | 9.52% (+1.88) | |
| May 08, 2026 | 2026 (Q1) | -18.60-20.85 | -14.09 | -48.00% (-6.76) | |
| Mar 25, 2026 | 2025 (Q4) | -21.38-22.36 | -11.27 | -98.33% (-11.08) | |
| Nov 12, 2025 | 2025 (Q3) | -18.32-19.73 | -16.91 | -16.67% (-2.82) | |
| Aug 12, 2025 | 2025 (Q2) | -16.19-19.73 | -14.09 | -40.00% (-5.64) | |
| May 13, 2025 | 2025 (Q1) | -15.97-14.09 | -14.09 | 0.00% (+0.00) | |
| Mar 25, 2025 | 2024 (Q4) | -17.85-11.27 | -16.91 | 33.33% (+5.64) | |
| Nov 12, 2024 | 2024 (Q3) | -16.91-16.91 | -14.09 | -20.00% (-2.82) | |
| Aug 12, 2024 | 2024 (Q2) | -16.91-14.09 | -22.54 | 37.50% (+8.45) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed